Intervention Review

Nebulised morphine for severe interstitial lung disease

  1. Riccardo Polosa1,*,
  2. Alexander Simidchiev2,
  3. E. Haydn Walters3

Editorial Group: Cochrane Airways Group

Published Online: 22 JUL 2002

Assessed as up-to-date: 4 MAY 2011

DOI: 10.1002/14651858.CD002872


How to Cite

Polosa R, Simidchiev A, Walters EH. Nebulised morphine for severe interstitial lung disease. Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD002872. DOI: 10.1002/14651858.CD002872.

Author Information

  1. 1

    Az. Ospedaliero-Universitaria Vittorio Emanuele -Osp. S. Marta, Catania, Italy

  2. 2

    Sofia, Bulgaria

  3. 3

    University of Tasmania, Menzies Research Institute, Hobart, Tasmania, Australia

*Riccardo Polosa, Az. Ospedaliero-Universitaria Vittorio Emanuele -Osp. S. Marta, Via G. Clementi 36, Catania, 95124, Italy. R.Polosa@soton.ac.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 22 JUL 2002

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.